questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Troubles hémorragiques
Troubles hémorragiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Temps de prothrombine
Temps de thromboplastine partielle activée
Antécédents familiaux
Hémophilie
Saignement
Évaluation clinique
Symptômes
5
Hémorragie interne
Selles sanglantes
Menstruations
Saignement menstruel
Saignement de nez
Troubles hémorragiques
Prévention
5
Prévention
Gestion des risques
Mode de vie
Alimentation équilibrée
Activités sportives
Prévention des blessures
Consultation médicale
Suivi médical
Traitements
5
Transfusion sanguine
Thérapie génique
Hémophilie
Facteurs de coagulation
Anticoagulants
Saignement
Classification des maladies
Traitement
Complications
5
Hémorragie interne
Choc hypovolémique
Qualité de vie
Soins médicaux
Infections
Transfusion sanguine
Gestion des complications
Traitement
Facteurs de risque
5
Antécédents familiaux
Maladies hépatiques
Troubles menstruels
Femmes
Médicaments
Anticoagulants
Maladies auto-immunes
Coagulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles hémorragiques : Questions médicales les plus fréquentes",
"headline": "Troubles hémorragiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles hémorragiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Troubles de l'hémostase",
"alternateName": "Hemostatic Disorders",
"url": "https://questionsmedicales.fr/mesh/D020141",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de l'hémostase",
"code": {
"@type": "MedicalCode",
"code": "D020141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémangiome caverneux",
"alternateName": "Hemangioma, Cavernous",
"url": "https://questionsmedicales.fr/mesh/D006392",
"about": {
"@type": "MedicalCondition",
"name": "Hémangiome caverneux",
"code": {
"@type": "MedicalCode",
"code": "D006392",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Réaction de Schwartzman",
"alternateName": "Shwartzman Phenomenon",
"url": "https://questionsmedicales.fr/mesh/D012790",
"about": {
"@type": "MedicalCondition",
"name": "Réaction de Schwartzman",
"code": {
"@type": "MedicalCode",
"code": "D012790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.515.810"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie du pool vide",
"alternateName": "Platelet Storage Pool Deficiency",
"url": "https://questionsmedicales.fr/mesh/D010981",
"about": {
"@type": "MedicalCondition",
"name": "Maladie du pool vide",
"code": {
"@type": "MedicalCode",
"code": "D010981",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytémie essentielle",
"alternateName": "Thrombocythemia, Essential",
"url": "https://questionsmedicales.fr/mesh/D013920",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytémie essentielle",
"code": {
"@type": "MedicalCode",
"code": "D013920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.463.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles hémorragiques",
"alternateName": "Hemorrhagic Disorders",
"code": {
"@type": "MedicalCode",
"code": "D006474",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Avrey Thau",
"url": "https://questionsmedicales.fr/author/Avrey%20Thau",
"affiliation": {
"@type": "Organization",
"name": "Thomas Jefferson University, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Brooke Saffren",
"url": "https://questionsmedicales.fr/author/Brooke%20Saffren",
"affiliation": {
"@type": "Organization",
"name": "Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "James D Anderst",
"url": "https://questionsmedicales.fr/author/James%20D%20Anderst",
"affiliation": {
"@type": "Organization",
"name": "Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Shannon L Carpenter",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Carpenter",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Thibault Coste",
"url": "https://questionsmedicales.fr/author/Thibault%20Coste",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatitis: A Review.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36881349",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11934-023-01150-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36685547",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.998447"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.",
"datePublished": "2024-10-20",
"url": "https://questionsmedicales.fr/article/39428439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-76355-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37271051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107624"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles hémorragiques",
"item": "https://questionsmedicales.fr/mesh/D006474"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles hémorragiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles hémorragiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles hémorragiques",
"description": "Comment diagnostiquer un trouble hémorragique ?\nQuels tests sont utilisés pour évaluer la coagulation ?\nLes antécédents familiaux sont-ils importants ?\nComment évaluer la gravité d'un saignement ?\nLes examens d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles hémorragiques",
"description": "Quels sont les symptômes courants des troubles hémorragiques ?\nComment reconnaître une hémorragie interne ?\nLes saignements menstruels peuvent-ils indiquer un trouble ?\nQuelles sont les manifestations cutanées des troubles hémorragiques ?\nLes saignements de nez sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles hémorragiques",
"description": "Comment prévenir les troubles hémorragiques ?\nLes vaccinations sont-elles importantes ?\nLe mode de vie influence-t-il ces troubles ?\nLes activités sportives doivent-elles être évitées ?\nLes consultations médicales régulières sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles hémorragiques",
"description": "Quels traitements sont disponibles pour les troubles hémorragiques ?\nComment traiter l'hémophilie ?\nLes anticoagulants sont-ils utilisés dans ces troubles ?\nQuelles sont les options pour les saignements sévères ?\nLes traitements varient-ils selon le type de trouble ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles hémorragiques",
"description": "Quelles complications peuvent survenir ?\nLes troubles hémorragiques peuvent-ils être mortels ?\nComment les troubles hémorragiques affectent-ils la qualité de vie ?\nLes troubles hémorragiques augmentent-ils le risque d'infections ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles hémorragiques",
"description": "Quels sont les facteurs de risque des troubles hémorragiques ?\nL'âge influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes maladies auto-immunes sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006474?mesh_terms=Prostatitis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble hémorragique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des antécédents médicaux, des tests de coagulation et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la coagulation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests courants incluent le temps de prothrombine (TP) et le temps de thromboplastine partielle activée (TTPa)."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles hémorragiques peuvent indiquer une prédisposition génétique."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité d'un saignement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par la quantité de sang perdu et l'impact sur la santé générale du patient."
}
},
{
"@type": "Question",
"name": "Les examens d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Parfois, des examens d'imagerie comme l'échographie peuvent être nécessaires pour détecter des hématomes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles hémorragiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des saignements fréquents, des ecchymoses, et des saignements des gencives."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs abdominales, des vertiges, et des selles noires ou sanglantes."
}
},
{
"@type": "Question",
"name": "Les saignements menstruels peuvent-ils indiquer un trouble ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des menstruations excessives peuvent signaler un trouble hémorragique sous-jacent."
}
},
{
"@type": "Question",
"name": "Quelles sont les manifestations cutanées des troubles hémorragiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ecchymoses, des pétéchies et des saignements sous-cutanés peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les saignements de nez sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les saignements de nez récurrents peuvent être un symptôme de troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles hémorragiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un diagnostic précoce, une gestion des facteurs de risque et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections qui aggravent les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une alimentation équilibrée, peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les activités sportives doivent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités à risque doivent être évitées pour prévenir les blessures et les saignements."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations régulières aident à surveiller et à gérer les troubles hémorragiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles hémorragiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des transfusions sanguines, des médicaments et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hémophilie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémophilie est traitée par des facteurs de coagulation administrés par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils utilisés dans ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les anticoagulants peuvent aggraver les saignements et ne sont pas recommandés."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour les saignements sévères ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments hémostatiques et, dans certains cas, une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de trouble ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend du type spécifique de trouble hémorragique et de sa gravité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies internes, des chocs hypovolémiques et des infections."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques peuvent-ils être mortels ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements non contrôlés peuvent entraîner des complications graves et potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Comment les troubles hémorragiques affectent-ils la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes et nécessiter des soins médicaux fréquents."
}
},
{
"@type": "Question",
"name": "Les troubles hémorragiques augmentent-ils le risque d'infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme les transfusions peuvent augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une gestion proactive et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles hémorragiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles hémorragiques augmente avec l'âge en raison de la dégradation des fonctions corporelles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions, comme les troubles menstruels, peuvent augmenter le risque chez les femmes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les anticoagulants, peuvent augmenter le risque de saignement."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter la coagulation et augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Thomas Jefferson University, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Division of Child Adversity and Resilience, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Oncology, and Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, MO, USA.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Affiliations :
AP-HP, Service de génétique moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Université de Paris, INSERM UMR-1141 Neurodiderot, Paris, France.
Publications dans "Troubles hémorragiques" :
2 publications dans cette catégorie
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, ChristianaCare, Newark, Delaware.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy. sergiobagnato@gmail.com.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Molecular Biology Laboratory, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Cardinal Ferrari Center, Fontanellato, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
RAN (Research in Advanced Neuro-Rehabilitation), S. Anna Institute, Crotone, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Neurorehabilitation and Spinal Units, ICS Maugeri, Institute of Pavia, Pavia, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Montecatone Rehabilitation Institute, Imola, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Clinical Pathology Laboratory, Provincial Health Authority of Caltanissetta, Caltanissetta, Italy.
Publications dans "Troubles hémorragiques" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Department of Ophthalmology, Hallym University Dongtan Sacred Heart Hospital, Hallym University Medical Center, Hwaseong-si, Gyeonggi-do, Republic of Korea.
Publications dans "Troubles hémorragiques" :
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Pathologies of the prostate in men are one of the most prevalent clinical conditions today [1]. Specifically, pelvic inflammatory disease such as prostatitis can cause symptoms and syndromes different...
Recent discoveries about the epidemiology and clinical classifications of prostatitis seem to incur in an increasingly individualized and directed management, with the aim of covering all the confluen...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
In recent observational studies, a potential link between prostatitis and prostate cancer (PCa) has been hinted at, yet the causality remains ambiguous. In our endeavor to scrutinize the conceivable c...
With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di...
We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ...
An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve...
This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...
We aimed to use Mendelian randomization (MR) to determine the causality between fifteen major mental disorders (MDs) and benign prostatic hyperplasia (BPH), prostate cancer (PCa), and prostatitis....
The main MR analysis was performed using the inverse variance-weighted (IVW) method....
The study found that insomnia (odds ratio [OR], 1.6190;...
Our findings provide clinicians with a basis for developing programs to prevent or treat MDs and prostatic diseases....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...
Although it is thought that prostatitis or benign prostatic hyperplasia (BPH) is related to prostate cancer (PCa), the underlying causal effects of these diseases are unclear....
We assessed the causal relationship between prostatitis or BPH and PCa using a two-sample Mendelian randomization (MR) approach. The data utilized in this study were sourced from genome-wide associati...
MR analysis showed that BPH had a significant causal effect on PCa (Odds Ratio = 1.209, 95% Confidence Interval: 0.098-0.281, P = 5.079 × 10...
This MR study supports that BPH has a positive causal effect on PCa, while genetically predicted prostatitis has no causal effect on PCa. Nonetheless, further studies should explore the underlying bio...
Inflammation is thought to affect the development of prostate cancer (PCa). By retrospectively investigating the database of the National Health Insurance Service, this study attempted to perform a re...
Participants were aged ≥ 50 years. Patients diagnosed with prostatitis between 2010 and 2013 and matched controls were followed up until 2019. We selected controls with matched propensity scores for a...
A total of 746,176 patients from each group were analyzed. The incidence of PCa was significantly higher in the group with prostatitis (1.8% vs 0.6%, p < 0.001). The HR for PCa was significantly highe...
Prostatitis is associated with an increased incidence of PCa. Acute prostatitis is associated with higher risk of PCa than chronic prostatitis. Clinicians should inform patients with prostatitis that ...
To analyse multiparametric magnetic resonance imaging (mpMRI) characteristics and appearance of histopathologically proven non-cancerous intraprostatic findings focussing on quantity of prostatitis an...
In this retrospective analysis consecutive patients with mpMRI followed by MRI/TRUS-fusion biopsy comprising targeted (TB) and systematic biopsy (SB) cores without prostate cancer (PC) at histopatholo...
Seventy-two patients were analysed. The median baseline characteristics were PSA 5.4 ng/ml (4.0-7.9), PI-RADS classification 3 (2-4), prostate volume 43 ml (33-57), and PSA density 0.13 ng/ml...
Quantity of atrophy and prostatitis had different influence on MRI characteristics and increased within higher PI-RADS classification. Younger men had diffuse hypointense changes at T2w images, but le...